Dicerna Pharmaceutic (DRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DRNA | GRAL | GPCR | ||
| Company | Dicerna Pharmaceutic | Grail Inc | Structure Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 38.21 | 73.90 | 41.18 | ||
| High | 38.24 | 74.49 | 41.18 | ||
| Low | 38.21 | 70.74 | 39.06 | ||
| Latest | 38.22 | 71.68 | 39.34 | ||
| Change | +0.22 | -2.24 | -0.83 | ||
| % Change | +0.58% | -3.03% | -2.07% | ||
| Volume | 5,568,900 | 1,247,700 | 507,000 | ||
| 20-Day Average Volume | 3,647,665 | 676,125 | 713,825 | ||
| Previous Close | 38.00 | 73.92 | 40.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.03 | 63.27 | 39.18 | ||
| 20-Day Raw Stochastic | 90.72% | 71.37% | 39.56% | ||
| 20-Day Relative Strength | 80.40 | 63.31 | 39.87 | ||
| Weighted Alpha | +35.17 | +163.02 | -20.00 | ||
| Today's Opinion | 88% Buy | 8% Sell | 72% Sell | ||
| Previous Opinion | 72% Buy | 8% Sell | 72% Sell | ||
| Last Month's Opinion | 24% Buy | 80% Sell | 40% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.08% since 12/17/21 | +5.63% since 05/21/26 | +1.42% since 05/21/26 | ||
| Low | 37.81 on 12/21/21 | 66.89 on 05/22/26 | 38.05 on 05/26/26 | ||
| High | 38.24 on 12/27/21 | 79.50 on 05/28/26 | 41.50 on 05/27/26 | ||
| 1-Month | |||||
| %Chg | +0.61% since 11/26/21 | +44.25% since 04/29/26 | -4.90% since 04/29/26 | ||
| Low | 37.78 on 12/10/21 | 50.38 on 04/30/26 | 35.78 on 05/18/26 | ||
| High | 38.26 on 12/03/21 | 79.50 on 05/28/26 | 44.78 on 05/05/26 | ||
| 3-Month | |||||
| %Chg | +83.31% since 09/27/21 | +34.66% since 02/27/26 | -37.54% since 02/27/26 | ||
| Low | 19.06 on 10/06/21 | 41.53 on 03/13/26 | 35.78 on 05/18/26 | ||
| High | 38.26 on 12/03/21 | 79.50 on 05/28/26 | 64.99 on 03/04/26 | ||
| 6-Month | |||||
| %Chg | +1.95% since 06/25/21 | -35.07% since 11/28/25 | +9.86% since 11/28/25 | ||
| Low | 19.06 on 10/06/21 | 41.50 on 02/23/26 | 30.94 on 12/04/25 | ||
| High | 40.14 on 07/20/21 | 118.84 on 01/22/26 | 94.90 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,986,090 | 3,076,290 | 2,796,090 | ||
| Shares Outstanding, K | 78,129 | 42,917 | 71,075 | ||
| Annual Sales | 164,310,000 | 147,170,000 | 0 | ||
| Annual Net Income | -112,750,000 | -408,350,000 | -141,200,000 | ||
| Last Quarter Sales | 62,950,000 | 40,790,000 | 0 | ||
| Last Quarter Net Income | -17,070,000 | -93,190,000 | -75,970,000 | ||
| 60-Month Beta | 0.80 | 3.03 | -1.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 11/09/21 | -2.29 on 05/05/26 | -0.35 on 05/07/26 | ||
| Earnings Date | 02/24/22 | 08/11/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||